arsenic has been researched along with busulfan in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 7 (87.50) | 18.7374 |
| 1990's | 1 (12.50) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Andersson, LC; Autero, M; Mustelin, T; Oetken, C; Ruutu, T; von Willebrand, M | 1 |
| Sears, DA | 1 |
| Almeyda, J; Levantine, A | 1 |
| Cappuccino, JG; Schmid, FA; Stock, CC; Tarnowski, GS | 1 |
| Babusiková, O; Jacz, K; Kalafut, F; Kuzma, I; Mungyerová, G | 1 |
| KISELEVA, AN; KUZ'MIN, DS; POVERGO, NS; ROZANOVA, LM; SHERMAN, SI; VAKULENKO, AD | 2 |
| NANETTI, L; VALLINI, R | 1 |
1 review(s) available for arsenic and busulfan
| Article | Year |
|---|---|
Drug induced changes in pigmentation.
Topics: Adrenocorticotropic Hormone; Anti-Inflammatory Agents; Antimalarials; Arsenic; Bismuth; Bleomycin; Busulfan; Chlorpromazine; Contraceptives, Oral; Cyclophosphamide; Gold; Humans; Hydantoins; Mercury; Phenazines; Phenolphthaleins; Phenothiazines; Pigmentation Disorders; Silver; Sulfones | 1973 |
1 trial(s) available for arsenic and busulfan
| Article | Year |
|---|---|
Experiences with malignant brain tumours in clinic and in tissue culture.
Topics: Adolescent; Adult; Aged; Alkylating Agents; Arsenicals; Astrocytoma; Brain Neoplasms; Busulfan; Clinical Trials as Topic; Culture Techniques; Cyclophosphamide; Female; Glioblastoma; Glioma; Humans; Male; Mannomustine; Middle Aged | 1965 |
6 other study(ies) available for arsenic and busulfan
| Article | Year |
|---|---|
Phenylarsine oxide augments tyrosine phosphorylation in hematopoietic cells.
Topics: Aged; Animals; Arsenicals; Blood Platelets; Busulfan; Cell Line; Dithiothreitol; Gene Rearrangement; Granulocytes; Humans; Hydroxyurea; Karyotyping; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Mice; Phosphates; Phosphoproteins; Phosphorylation; Phosphotyrosine; Protein Tyrosine Phosphatases; Tyrosine | 1992 |
History of the treatment of chronic myelocytic leukemia.
Topics: Arsenic; Bone Marrow Transplantation; Busulfan; History, 18th Century; History, 19th Century; History, 20th Century; Humans; Interferons; Leukemia, Myeloid; Prognosis; Whole-Body Irradiation | 1988 |
Chemotherapy studies in an animal tumor spectrum. II. Sensitivity of tumors to fourteen antitumor chemicals.
Topics: Animals; Antineoplastic Agents; Arsenicals; Busulfan; Cyclophosphamide; Dactinomycin; Diethylstilbestrol; Floxuridine; Fluorouracil; Hydrocortisone; Mercaptopurine; Methotrexate; Mice; Mitomycins; Neoplasms, Experimental; Urethane; Vinblastine | 1966 |
[Comparative evaluation of the effectiveness of certain therapeutic methods in chronic leukemias; roentgen rays, radioactive phosphorus, urethane, embichine, arsenic, myleran. IV].
Topics: Arsenic; Busulfan; Chronic Disease; Leukemia; Phosphorus; Phosphorus, Dietary; Radioactivity; Urethane; X-Rays | 1959 |
[Comparative evaluation of the effectiveness of certain therapeutic methods in chronic leukemias; roentgen rays, radioactive phosphorus, urethane, embichine, arsenic, myleran. V].
Topics: Arsenic; Busulfan; Chronic Disease; Leukemia; Phosphorus; Phosphorus, Dietary; Radioactivity; Urethane; X-Rays | 1959 |
[PRESENT STATE OF ANTINEOPLASTIC CHEMOTHERAPY FROM THE PHARMACOLOGIC POINT OF VIEW].
Topics: Acridines; Antineoplastic Agents; Arsenicals; Azaguanine; Azaserine; Busulfan; Cell Division; Chloramines; Colchicine; Humans; Mercaptopurine; Pharmacology; Purines; Thiotepa; Triethylenemelamine | 1963 |